{"meshTagsMajor":["Communication"],"meshTags":["Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Communication","Education, Continuing","Female","Health Personnel","Humans","Lung Neoplasms","Molecular Targeted Therapy","National Health Programs","Oncogene Proteins, Fusion","Precision Medicine","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor, ErbB-2","Trastuzumab","United Kingdom"],"meshMinor":["Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Breast Neoplasms","Education, Continuing","Female","Health Personnel","Humans","Lung Neoplasms","Molecular Targeted Therapy","National Health Programs","Oncogene Proteins, Fusion","Precision Medicine","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor, ErbB-2","Trastuzumab","United Kingdom"],"publicationTypes":["Journal Article"],"title":"Stratified medicines: towards better treatment for disease.","pubmedId":"24581625"}